CRBP vs HBAN · $102.3M cap vs P/E 13, rev $1.56B
Corbus Pharmaceuticals Holding (CRBP) versus Huntington Bancshares Incorporated (HBAN) — a side-by-side from cached financials, not a winner call.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
CRBP does not have a complete income-statement cache yet.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
CRBP currently screens at market cap $102.3M. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Not investment advice. Open the CRBP and HBAN stock pages for the full models.
Not investment advice.